MoneyWorks4Me

With no major difference for the quarter endedSeptember 2022 , the total revenue stood at Rs. 358.52  millions.The Net Profit of the company registered a slight decline of -13.84% to Rs. 68.67  millions from Rs. 79.70 millions.A decline of 98.78 millions was observed in the OP in the quarter ended September 2022 from 114.59 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 358.52 355.08 0.97 669.84 626.88 6.85 1239.80 1092.94 13.44
Other Income 12.61 11.91 5.88 24.04 23.86 0.75 49.49 43.08 14.88
PBIDT 98.78 114.59 -13.80 182.93 180.14 1.55 322.04 241.52 33.34
Interest 0.93 1.09 -14.68 1.80 2.12 -15.09 4.35 4.74 -8.23
PBDT 97.85 113.50 -13.79 181.13 178.02 1.75 317.69 236.78 34.17
Depreciation 5.45 4.54 20.04 10.80 8.88 21.62 18.99 20.35 -6.68
PBT 92.40 108.96 -15.20 170.33 169.14 0.70 298.70 216.43 38.01
TAX 23.73 29.26 -18.90 42.13 42.93 -1.86 75.74 51.39 47.38
Deferred Tax -1.27 -0.74 71.62 -2.10 -1.35 55.56 2.96 -3.91 -175.70
PAT 68.67 79.70 -13.84 128.20 126.21 1.58 222.96 165.04 35.09
Equity 45.89 45.89 0.00 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 27.55 32.27 -14.62 27.31 28.74 -4.96 25.98 22.10 17.54
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..